Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.
Also called NCT04790279
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT04790279
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04790279. Randomized; no masking; primary purpose treatment. Start 2021-04-09 (actual); primary completion 2022-12-13 (actual). Results posted on 2024-10-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
- Condition
- Hypertension in Pregnancy
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- NIFEdipine ER
- Lead sponsor
- Prisma Health-Upstate
Record details
- Record id
cardio:ct-nct04790279- Content hash
979780149ee58f69c29ef5c974940654de2551763eac76b0dd6abe96ec50e9e5